These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 10614922)

  • 1. Medical treatment of thyroid-associated orbitopathy.
    Prummel MF
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 5():S198-200. PubMed ID: 10614922
    [No Abstract]   [Full Text] [Related]  

  • 2. What can the European Multicenter Trial on the treatment of Graves' disease with antithyroid drugs teach us about the course of thyroid-associated orbitopathy (TAO)? European Multicenter Trial Group.
    Benker G; Kahaly GJ; Reinwein D
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 5():S186-9. PubMed ID: 10614919
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonsteroid immunosuppressants in endocrine orbitopathy.
    Kahaly G
    Exp Clin Endocrinol; 1991 May; 97(2-3):316-9. PubMed ID: 1915649
    [No Abstract]   [Full Text] [Related]  

  • 4. [Managing Graves' orbitopathy].
    Kahaly GJ
    Z Arztl Fortbild Qualitatssich; 2004 May; 98 Suppl 5():63-6. PubMed ID: 15255315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The endocrinological management of thyroid associated orbitopathy in relation to severity and activity of the disease].
    Michałek K; Waśko R; Sowiński J
    Przegl Lek; 2004; 61(8):838-40. PubMed ID: 15789911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy for thyroid-associated orbitopathy.
    Kahaly GJ; Roesler HP; Kutzner J; Pitz S; Müller-Forell W; Beyer J; Mann W
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 5():S201-7. PubMed ID: 10614923
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathogenetic and clinical aspects of endocrine ophthalmopathy.
    Prummel MF
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 3():S75-8. PubMed ID: 10522810
    [No Abstract]   [Full Text] [Related]  

  • 8. Does radiotherapy have a role in the management of thyroid orbitopathy? View 2.
    Mourits MP
    Br J Ophthalmol; 2002 Jan; 86(1):104-6. PubMed ID: 11806399
    [No Abstract]   [Full Text] [Related]  

  • 9. Radioiodine therapy and thyroid-associated orbitopathy: risk factors and preventive effects of glucocorticoids.
    Dietlein M; Dederichs B; Weigand A; Schicha H
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 5():S190-4. PubMed ID: 10614920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of malignant exophthalmos with immunosuppressive agents].
    Simonin ; Saracco ; L'Epine-Bouyrie ; Vola
    Bull Soc Ophtalmol Fr; 1969 Feb; 69(2):211-3. PubMed ID: 5408908
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of immunosuppressive therapy on the long acting thyroid stimulator (LATS) and the clinical picture in patients with localized myxedema and exophthalmus].
    Depisch D; Höfer R; Schatz H
    Wien Klin Wochenschr; 1969 Jan; 81(1):8-10. PubMed ID: 5818436
    [No Abstract]   [Full Text] [Related]  

  • 12. Positive effect of bromocriptine treatment in Graves disease orbitopathy.
    Kołodziej-Maciejewska H; Reterski Z
    Exp Clin Endocrinol; 1985 Dec; 86(2):241-2. PubMed ID: 3841515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoids in the medical management of Graves' ophthalmopathy.
    Hart RH; Perros P
    Minerva Endocrinol; 2003 Sep; 28(3):223-31. PubMed ID: 14605604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Graves' orbitopathy].
    Balázs C
    Orv Hetil; 2006 Jun; 147(22):1011-7. PubMed ID: 16913090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid eye disease.
    Mizen TR
    Semin Ophthalmol; 2003 Dec; 18(4):243-7. PubMed ID: 15513011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Administration of levothyroxine in the treatment of Basedow disease].
    Hörmann R
    Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():47-52. PubMed ID: 10355050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical treatment for thyroid-associated ophthalmopathy.
    Perros P; Kendall-Taylor P
    Thyroid; 2002 Mar; 12(3):241-4. PubMed ID: 11952047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid failure after potassium iodide treatment of diffuse toxic goiter.
    Wood LC; Maloof F
    Trans Assoc Am Physicians; 1975; 88():235-47. PubMed ID: 1243786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid ophthalmopathy.
    Salvi MG; Neri F
    Curr Ther Endocrinol Metab; 1994; 5():77-81. PubMed ID: 7704806
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.
    Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R
    Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.